Search research articles
Contact Us
Filters
Showing results (1-10 of 209) with videos related to
Page
of 21
Sort By:
Expert Review of Cardiovascular Therapy
|
June 12, 2013
The next 10 years in antihypertensive treatment. Interview by Tanya Stezhka
Rhonda M Cooper-Dehoff
Clinical Cardiology
|
July 4, 2007
Metabolic syndrome and cardiovascular disease: challenges and opportunities
Rhonda M Cooper-DeHoff, Carl J Pepine
Current Hypertension Reports
|
July 23, 2015
Genetics of resistant hypertension: a novel pharmacogenomics phenotype
Nihal El Rouby, Rhonda M Cooper-DeHoff
The American Journal of Medicine
|
April 8, 2018
2017 Is Banner Year for Drug Approvals by the Food and Drug Administration
Alex M Ebied, Rhonda M Cooper-DeHoff
Expert Review of Cardiovascular Therapy
|
June 10, 2009
Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects
Jason H Karnes, Rhonda M Cooper-DeHoff
Journal of the American College of Cardiology
|
September 11, 2004
Cardiovascular therapies and risk for development of diabetes
Carl J Pepine, Rhonda M Cooper-Dehoff
Current Hypertension Reports
|
May 24, 2013
Generic drugs for hypertension: are they really equivalent?
Rhonda M Cooper-DeHoff, William J Elliott
Diabetes & Metabolic Syndrome
|
June 8, 2014
Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009-10
Stacy A Voils, Rhonda M Cooper-DeHoff
Expert Review of Cardiovascular Therapy
|
June 10, 2010
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D Duarte, Rhonda M Cooper-DeHoff
Nature Reviews. Nephrology
|
November 24, 2015
Hypertension pharmacogenomics: in search of personalized treatment approaches
Rhonda M Cooper-DeHoff, Julie A Johnson
Page
of 21
Search research articles
Search
Showing results (1-10 of 209) with videos related to
Sort By:
Page
of 21
Expert Review of Cardiovascular Therapy
|
June 12, 2013
The next 10 years in antihypertensive treatment. Interview by Tanya Stezhka
Rhonda M Cooper-Dehoff
Clinical Cardiology
|
July 4, 2007
Metabolic syndrome and cardiovascular disease: challenges and opportunities
Rhonda M Cooper-DeHoff, Carl J Pepine
Current Hypertension Reports
|
July 23, 2015
Genetics of resistant hypertension: a novel pharmacogenomics phenotype
Nihal El Rouby, Rhonda M Cooper-DeHoff
The American Journal of Medicine
|
April 8, 2018
2017 Is Banner Year for Drug Approvals by the Food and Drug Administration
Alex M Ebied, Rhonda M Cooper-DeHoff
Expert Review of Cardiovascular Therapy
|
June 10, 2009
Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects
Jason H Karnes, Rhonda M Cooper-DeHoff
Journal of the American College of Cardiology
|
September 11, 2004
Cardiovascular therapies and risk for development of diabetes
Carl J Pepine, Rhonda M Cooper-Dehoff
Current Hypertension Reports
|
May 24, 2013
Generic drugs for hypertension: are they really equivalent?
Rhonda M Cooper-DeHoff, William J Elliott
Diabetes & Metabolic Syndrome
|
June 8, 2014
Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009-10
Stacy A Voils, Rhonda M Cooper-DeHoff
Expert Review of Cardiovascular Therapy
|
June 10, 2010
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D Duarte, Rhonda M Cooper-DeHoff
Nature Reviews. Nephrology
|
November 24, 2015
Hypertension pharmacogenomics: in search of personalized treatment approaches
Rhonda M Cooper-DeHoff, Julie A Johnson
Page
of 21